Aerovate Therapeutics
AVTE
#9165
Rank
$73.14 M
Marketcap
$2.53
Share price
-1.17%
Change (1 day)
-85.12%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $10.46 Million USD

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are $10.46 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31$8.55 M190.59%
2021-12-31$2.94 M-83.69%
2020-12-31$18.05 M152.33%
2019-12-31$7.15 M